By Colin Kellaher

 

Medtronic PLC on Wednesday said it agreed to buy French implant-technologies company Medicrea International S.A. for about 135.4 million euros ($154.4 million) in a deal that bolsters its spine-surgery business.

The Dublin-based medical-technology company said it will pay EUR7.00 a share in cash for Medicrea, a 21.5% premium to Tuesday's closing price of EUR5.76.

Medtronic said the acquisition will make it the first company to offer an integrated spinal-surgery solution that includes artificial intelligence-driven surgical planning, personalized spinal implants and robotic-assisted surgery.

Medtronic said it expects to complete the acquisition by the end of 2020, adding that the deal will be immaterial to its adjusted per-share earnings in the first two fiscal years before turning accretive in fiscal 2023.

Paris-listed shares of Medicrea were recently up 20.5% to EUR6.94.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

July 15, 2020 06:22 ET (10:22 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Medtronic Charts.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Medtronic Charts.